Status:
COMPLETED
Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Adult Primary Liver Cancer
Kidney Tumor
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive ...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results. OUTLINE...
Eligibility Criteria
Inclusion
- There are no restrictions on life expectancy
- Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed
- Patients of any ethnic background
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Patients should not be taking other investigational agents
- No requirements due to co-morbid disease or intercurrent illness, as needed
- No restrictions on allergic reactions as no imaging agent will be used
- Concomitant medications for treatment of the target lesion
- Pregnant or nursing patients will be excluded from the study
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT01908166
Start Date
January 1 2014
End Date
November 1 2016
Last Update
June 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University, School of Medicine
Stanford, California, United States, 94305